Clinical Trial Update: ALF-STONE: Alfuzosin in Uretheric Stones [Phase 3]

View source ↗

Summary

Sanofi-sponsored Phase 3 trial of Alfuzosin for benign prostatic hyperplasia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Hyperplasia | Phase 3 | Status: TERMINATED